Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer (Q44754094)
Jump to navigation
Jump to search
scientific article published in February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer |
scientific article published in February 2004 |
Statements
1 reference
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer (English)
1 reference
1 reference
C Monnerat
1 reference
R Henriksson
1 reference
T Le Chevalier
1 reference
S Novello
1 reference
P Berthaud
1 reference
E Raymond
1 reference
1 February 2004
1 reference
1 reference
1 reference
Identifiers
1 reference